Milestones
Founded in 2003, Regen Lab
has become a global reference
thanks to its commitment to innovation,
quality, and the effectiveness
of its therapeutic solutions.
Here’s how we have transformed the medical landscape over the past two decades.
A solid regulatory track record across all major markets and successful operational deployment…
…leading to a global and integrated major player in tissue engineering
Foundation by Antoine Turzi
Founded in 2003 by the visionary Antoine Turzi, Regen Lab SA embarked on its journey with a clear mission: to enhance the quality of life for patients through innovative medical solutions based on cellular regeneration. From the outset, the company focused on developing therapies utilizing the healing properties of platelet-rich plasma (PRP).
ISO 13485
RegenKit first approval in bone graft
A new state-of-theart in Lausanne, Switzerland
With our unwavering commitment to research and development, we have created a range of revolutionary products known for their effectiveness and safety. Today, our PRP therapy solutions are used in over 160 countries by thousands of renowned practitioners.
Cellular Matrix first approval
Regen Lab quickly distinguished itself with its pioneering approach and ability to turn innovative ideas into tangible products. The launch of our patented device for PRP-HA combination preparation marked a decisive mileston.
Launch of Cellular Matrix in Europe
US phase III for Cellular Matrix RegenKit first approval in chronic WoundCare in China
Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region. Our strategic partnerships with leading medical institutions and our presence at major global conferences testify to our leadership in the field of regenerative medicine.
Operational new manufacture in New York State (USA)
USA Granted patents for covering PRP alone medical devices
Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.
RegenKit cleared for WoundCare indication
New subsidiaries in Morocco and Dubai
EU-MDR certification RegenKit & Cellular Matrix
Our products are manufactured to the highest industry standards, and we continually invest in quality audits and international certifications to ensure the safety and efficacy of our solutions.
Inauguration in les Ulis near Paris
Foundation by Antoine Turzi
Founded in 2003 by the visionary Antoine Turzi, Regen Lab SA embarked on its journey with a clear mission: to enhance the quality of life for patients through innovative medical solutions based on cellular regeneration.
RegenKit first approval in bone graft
A new state-of-theart in Lausanne, Switzerland
We have created a range of revolutionary products known for their effectiveness and safety. Today, our PRP therapy solutions are used in over 160 countries by thousands of renowned practitioners.
Cellular Matrix first approval in osteoarthritis and skin care
Launch of Cellular Matrix in Europe
US phase III for Cellular Matrix RegenKit first approval in chronic WoundCare in China
Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region.
Operational new manufacture in New York State (USA)
USA Granted patents for covering PRP alone medical devices
Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.
RegenKit cleared for WoundCare indication
New subsidiaries in Morocco and Dubai
EU-MDR certification RegenKit & Cellular Matrix
Our products are manufactured to the highest industry standards, and we continually invest in quality audits and international certifications to ensure the safety and efficacy of our solutions.
New laboratory in les Ulis near Paris
Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices.